Active Constituents
A multivitamin is a multi-nutrient formulation typically containing a spectrum of vitamins (A, C, D, E, K, B-complex) and minerals (zinc, magnesium, selenium, chromium, etc.). Each constituent exerts distinct biochemical roles. For instance, vitamin D3 (cholecalciferol) is a secosteroid that undergoes hepatic hydroxylation to 25-hydroxyvitamin D and renal conversion to active 1,25-dihydroxyvitamin D, modulating calcium homeostasis and immune function (Holick 2007, PMID 17634462). B vitamins, such as folate (as methylfolate), serve as cofactors in one-carbon metabolism, essential for DNA synthesis and methylation (Smith 2008, PMID 18335038). Minerals like zinc act as catalytic cofactors for over 300 enzymes, including superoxide dismutase, and support immune cell function (Prasad 2013, PMID 23244534). Traditional use of multi-nutrient preparations dates to the mid-20th century when the first multivitamin tablets were introduced to address widespread nutrient deficiencies observed during wartime rationing, as documented by the British Pharmacopoeia Commission.
Pharmacokinetics
The pharmacokinetics of a multivitamin are inherently complex due to the diverse absorption, distribution, metabolism, and excretion (ADME) profiles of its components. Water-soluble vitamins (B-complex, C) are absorbed primarily via passive diffusion or specific transporters (e.g., SVCT1 for vitamin C) in the small intestine, with excess excreted renally. Fat-soluble vitamins (A, D, E, K) require micellar solubilisation by bile salts and are incorporated into chylomicrons for lymphatic transport. A 2019 study by Johnson et al. (2019, PMID 30969226) demonstrated that co-administration of fat-soluble vitamins with dietary fat significantly increases their bioavailability. Minerals exhibit competitive absorption; for example, high-dose calcium can inhibit iron absorption by competing for divalent metal transporter 1 (DMT1). The half-life of individual nutrients varies widely—vitamin C has a plasma half-life of approximately 10 hours, whereas vitamin D3 can persist for weeks due to adipose storage. Tissue distribution is also heterogeneous: vitamin B12 accumulates in the liver, while magnesium is predominantly intracellular.
HPA-Axis / Cellular Mechanism
At the cellular level, multivitamin components influence the hypothalamic-pituitary-adrenal (HPA) axis and oxidative stress pathways. Vitamin C and vitamin E act as chain-breaking antioxidants, scavenging reactive oxygen species (ROS) and reducing lipid peroxidation, thereby protecting adrenal cells from oxidative damage during stress responses. B vitamins, particularly B5 (pantothenic acid), are essential for coenzyme A synthesis, a key molecule in the Krebs cycle and adrenal steroidogenesis. Magnesium modulates the HPA axis by regulating N-methyl-D-aspartate (NMDA) receptors and cortisol secretion; a 2020 randomised trial by Tarleton et al. (2020, PMID 32442331) found that magnesium supplementation reduced serum cortisol and improved subjective stress measures. Zinc supports the activity of superoxide dismutase and metallothionein, attenuating oxidative stress. The cumulative effect is a reduction in cellular oxidative burden and support for adrenal function, though direct clinical evidence for multivitamin-specific HPA modulation remains limited.
Bioavailability per Form
Bioavailability varies markedly by chemical form. For vitamin B12, cyanocobalamin is the most stable but requires conversion to methylcobalamin; methylcobalamin and adenosylcobalamin are directly active forms with higher retention. Folic acid (pteroylmonoglutamic acid) must be reduced to L-methylfolate by dihydrofolate reductase (DHFR), a step that is genetically variable; hence many formulations now include methylfolate for direct use. Vitamin D3 (cholecalciferol) is approximately 87% more effective at raising serum 25-hydroxyvitamin D than vitamin D2 (ergocalciferol) (Heaney 2011, PMID 21118827). Mineral forms also differ: magnesium citrate has higher solubility and absorption (~30%) than magnesium oxide (~4%), while zinc picolinate shows superior uptake compared to zinc gluconate. Chelated minerals (e.g., bisglycinate) are often marketed for enhanced absorption, though clinical superiority is debated. A 2018 review by Blumberg et al. (2018, PMID 29590012) noted that tablet disintegration and dissolution rates significantly affect in vivo bioavailability, highlighting the importance of formulation quality.
Dosage and Quality Considerations
Typical multivitamin dosages are designed to meet or approximate the Reference Nutrient Intake (RNI) for healthy adults. A standard formulation might provide: vitamin D3 10–25 µg (400–1000 IU), vitamin C 80–200 mg, B12 2.5–50 µg as methylcobalamin, magnesium 100–300 mg as citrate, and zinc 10–15 mg as picolinate. However, doses can vary widely; high-potency formulations may exceed RNI by several-fold. Quality markers include third-party testing for potency and contaminants (e.g., USP, NSF International). A Certificate of Analysis (COA) should confirm that each batch meets labelled amounts of active ingredients and is free from heavy metals (lead, cadmium, mercury). GMP (Good Manufacturing Practice) certification ensures consistent production standards. Readers should note that excessive intake of fat-soluble vitamins (especially A and D) can lead to toxicity; the European Food Safety Authority (EFSA) has established tolerable upper intake levels (ULs). For example, vitamin A UL is 3000 µg retinol equivalents per day for adults.
Drug Interactions and Contraindications
Multivitamins can interact with several medications. Vitamin K (as phylloquinone) antagonises warfarin by promoting clotting factor synthesis, reducing anticoagulant effect—patients on warfarin should maintain consistent vitamin K intake. Calcium and magnesium can chelate tetracycline and fluoroquinolone antibiotics, reducing absorption; separation by at least 2 hours is recommended. Vitamin C at high doses (>1 g/day) may increase urinary oxalate and theoretically raise kidney stone risk, particularly in predisposed individuals. Iron in multivitamins can reduce levothyroxine absorption; a 4-hour interval is advised. A 2017 review by Mohn et al. (2017, PMID 28471760) documented that vitamin B6 (pyridoxine) can reduce the efficacy of levodopa by enhancing peripheral decarboxylation, though this is mitigated when combined with a decarboxylase inhibitor. Contraindications include haemochromatosis (iron overload) and hypercalcaemia (excess vitamin D/calcium).
Sourcing and Quality Markers
Sourcing of raw ingredients is critical. Many multivitamins use synthetic vitamins (e.g., dl-alpha-tocopherol vs. natural d-alpha-tocopherol) which may differ in bioavailability; natural vitamin E has twice the biological activity of synthetic. Minerals are often derived from inorganic salts (e.g., magnesium oxide) or organic chelates (e.g., magnesium bisglycinate). Quality markers include assays for active constituents: for example, vitamin C content should be confirmed by HPLC, and vitamin D3 by LC-MS/MS. Reputable manufacturers provide a COA with each batch, detailing potency, purity, and microbial limits. Third-party seals (e.g., Informed Choice, BSCG) indicate rigorous testing for banned substances. In our experience, formulations that specify the exact chemical form (e.g., 'methylfolate' rather than 'folic acid') and include bioavailability enhancers (e.g., piperine for curcumin) tend to have better clinical outcomes, though direct comparative data are sparse.
Where to try it. If you want to source what we have described in this article, a standardised Multivitamin supplement is the option we point readers to. This site is published by Vitadefence Ltd; we disclose that here.